The latest announcement is out from Jiangsu Recbio Technology Co., Ltd. Class H ( ($HK:2179) ). Jiangsu Recbio Technology Co., Ltd. has received ...

A new injectable vaccine to protect dogs aged 8 weeks and older against kennel cough ( Bordetella bronchiseptica) is now ...

"If you can unlock triple digit titers this is the real game that's needed to achieve competitive pricing and profitability" ...

The global molecular cloning market size is calculated at USD 5.53 billion in 2025 and is expected to reach around USD 8.89 billion by 2034, growing at a CAGR of 5.4% for the forecasted period.Ottawa, ...

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...

CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize ...

Continued execution on collaborations and exploratory investigator-initiated studies with institutional partners Secured net ...

Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relationsAdvanced mu ...

Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...

Sanyou Bio and Yugong Biotoday announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step to deepen their collaboration in the development of high-end ...

Study finds protein traits and CHO-cell gene programs drive therapeutic protein yields, guiding biomanufacturing.